Krystal Biotech buy Guggenheim
Start price
07.05.25
/
50%
€120.90
Target price
07.05.26
€166.60
Performance (%)
79.32%
Price
30.12.25
€216.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Krystal Biotech has seen massive gains of 79.32%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 0.790% | 0.790% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Guggenheim from $195.00 to $189.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Guggenheim for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€161.18
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
